Keating Investment Counselors Inc Bristol Myers Squibb CO Transaction History

Keating Investment Counselors Inc

$229 Million
Q4 2024

A detailed history of Keating Investment Counselors Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Keating Investment Counselors Inc holds 11,417 shares of BMY stock, worth $684,905. This represents 0.28% of its overall portfolio holdings.

Number of Shares

11,417

Previous 8,757 30.38%

Holding current value

$684,905

Previous $453,000 42.38%

% of portfolio

0.28%

Previous 0.19%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 31, 2025	BUY	$51.92 - $59.94 $138,107 - $159,440	2,660 Added 30.38%	11,417 $645,000
Q3 2024 Nov 12, 2024	SELL	$39.66 - $51.75 $63,455 - $82,800	-1,600 Reduced 15.45%	8,757 $453,000
Q2 2024 Aug 06, 2024	SELL	$40.25 - $52.99 $50,513 - $66,502	-1,255 Reduced 10.81%	10,357 $430,000
Q1 2024 May 07, 2024	SELL	$47.98 - $54.4 $404,231 - $458,320	-8,425 Reduced 42.05%	11,612 $629,000
Q4 2023 Feb 07, 2024	SELL	$48.48 - $57.85 $4,848 - $5,785	-100 Reduced 0.5%	20,037 $1.03 Million
Q2 2023 Aug 02, 2023	SELL	$63.71 - $70.74 $82,823 - $91,962	-1,300 Reduced 6.06%	20,137 $1.29 Million
Q1 2023 May 04, 2023	BUY	$65.71 - $74.53 $6,570 - $7,453	100 Added 0.47%	21,437 $1.49 Million
Q4 2022 Feb 08, 2023	BUY	$68.48 - $81.09 $116,416 - $137,853	1,700 Added 8.66%	21,337 $1.53 Million
Q3 2022 Nov 03, 2022	SELL	$0.13 - $76.84 $6 - $3,842	-50 Reduced 0.25%	19,637 $1.4 Million
Q2 2022 Aug 03, 2022	SELL	$72.62 - $79.98 $10,893 - $11,997	-150 Reduced 0.76%	19,687 $1.52 Million
Q1 2022 Apr 28, 2022	SELL	$61.48 - $73.72 $6,148 - $7,372	-100 Reduced 0.5%	19,837 $1.45 Million
Q3 2021 Oct 27, 2021	SELL	$59.17 - $69.31 $5,917 - $6,931	-100 Reduced 0.5%	19,937 $1.18 Million
Q1 2021 Apr 26, 2021	SELL	$59.34 - $66.74 $117,196 - $131,811	-1,975 Reduced 8.97%	20,037 $1.27 Million
Q3 2020 Oct 23, 2020	SELL	$57.43 - $63.64 $11,486 - $12,728	-200 Reduced 0.9%	22,012 $1.33 Million
Q4 2019 Jan 28, 2020	SELL	$49.21 - $64.19 $2,952 - $3,851	-60 Reduced 0.27%	22,212 $1.43 Million
Q3 2019 Oct 28, 2019	SELL	$42.77 - $50.71 $87,678 - $103,955	-2,050 Reduced 8.43%	22,272 $1.13 Million
Q1 2019 Apr 22, 2019	SELL	$45.12 - $53.8 $27,072 - $32,280	-600 Reduced 2.41%	24,322 $1.16 Million
Q3 2018 Oct 30, 2018	SELL	$55.19 - $62.25 $71,747 - $80,925	-1,300 Reduced 4.96%	24,922 $1.55 Million
Q2 2018 Aug 01, 2018	SELL	$50.53 - $62.98 $15,159 - $18,894	-300 Reduced 1.13%	26,222 $1.45 Million
Q1 2018 May 11, 2018	SELL	$59.92 - $68.98 $201,331 - $231,772	-3,360 Reduced 11.24%	26,522 $1.68 Million
Q3 2017 Nov 09, 2017	SELL	$55.23 - $63.74 $11,046 - $12,748	-200 Reduced 0.66%	29,882 $1.91 Million
Q2 2017 Aug 10, 2017	BUY	N/A	30,082	30,082 $1.68 Million

Others Institutions Holding BMY

# of Institutions

2,762

Shares Held

1.57B

Call Options Held

28M

Put Options Held

28.7M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $128B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keating Investment Counselors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Keating Investment Counselors Inc with notifications on news.

Account

Keating Investment Counselors Inc Bristol Myers Squibb CO Transaction History